Trade ATYR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
aTyr Pharma, Inc. (ATYR) is trading at US$0.36, down 3.59% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$49.19M. Over the past 52 weeks, ATYR has traded between US$0.36 and US$1.12. On Syfe you can trade ATYR with $0 commission and add it to your watchlist.
| Previous close | US$0.38 |
|---|---|
| Market cap | US$49.19M |
| 52-week range | US$0.36 – US$1.12 |
| Volume | 1.26M |
| Exchange | US |
Add to Watchlist
Set Price Alert
aTyr Pharma, Inc.
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Year: 2015
Update: ATyr Pharma Fiscal Q2 Loss Narrows; Announces Restructuring Plans
Aug 7, 8:39 PM · MT Newswires
ATyr Pharma Fiscal Q2 Loss Narrows
Aug 7, 8:14 PM · MT Newswires
aTyr Pharma, Inc. (ATYR) stock is trading at US$0.36, -3.59% from the previous close of US$0.38.
The market cap for aTyr Pharma, Inc. (ATYR) stock is approximately US$49.19M.
The 52-week high for aTyr Pharma, Inc. (ATYR) stock is US$1.12.
The 52-week low for aTyr Pharma, Inc. (ATYR) stock is US$0.36.
aTyr Pharma, Inc. (ATYR) does not currently pay a dividend.
Stay on top of ATYR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
